Enhancing titres of therapeutic viral vectors using the transgene repression in vector production (TRiP) system

H. E. Maunder, J. Wright, B. R. Kolli, C. R. Vieira, T. T. Mkandawire, S. Tatoris, V. Kennedy, S. Iqball, G. Devarajan, S. Ellis, Y. Lad, N. G. Clarkson, K. A. Mitrophanous and D. C. Farley ()
Additional contact information
H. E. Maunder: Oxford BioMedica Ltd.
J. Wright: Oxford BioMedica Ltd.
B. R. Kolli: Oxford BioMedica Ltd.
C. R. Vieira: Oxford BioMedica Ltd.
T. T. Mkandawire: Oxford BioMedica Ltd.
S. Tatoris: Oxford BioMedica Ltd.
V. Kennedy: Oxford BioMedica Ltd.
S. Iqball: Oxford BioMedica Ltd.
G. Devarajan: Oxford BioMedica Ltd.
S. Ellis: Oxford BioMedica Ltd.
Y. Lad: Oxford BioMedica Ltd.
N. G. Clarkson: Oxford BioMedica Ltd.
K. A. Mitrophanous: Oxford BioMedica Ltd.
D. C. Farley: Oxford BioMedica Ltd.

Nature Communications, 2017, vol. 8, issue 1, 1-13

Abstract: Abstract A key challenge in the field of therapeutic viral vector/vaccine manufacturing is maximizing production. For most vector platforms, the ‘benchmark’ vector titres are achieved with inert reporter genes. However, expression of therapeutic transgenes can often adversely affect vector titres due to biological effects on cell metabolism and/or on the vector virion itself. Here, we exemplify the novel ‘Transgene Repression In vector Production’ (TRiP) system for the production of both RNA- and DNA-based viral vectors. The TRiP system utilizes a translational block of one or more transgenes by employing the bacterial tryptophan RNA-binding attenuation protein (TRAP), which binds its target RNA sequence close to the transgene initiation codon. We report enhancement of titres of lentiviral vectors expressing Cyclo-oxygenase-2 by 600-fold, and adenoviral vectors expressing the pro-apoptotic gene Bax by >150,000-fold. The TRiP system is transgene-independent and will be a particularly useful platform in the clinical development of viral vectors expressing problematic transgenes.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms14834 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14834

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms14834

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().